At SkinnyRx, licensed doctors prescribe GLP-1 treatment and support patients throughout their weight loss journey, helping you manage side effects and stay on track
Just two weeks later, on 1 April 2026, the FDA approved Foundayo, Eli Lillys brand name for orforglipron, making it the first small-molecule, non-peptide oral GLP-1 receptor agonist approved for chronic weight management
If the drugs are directly both improving weight reduction and cancer reduction, then we need to double down. Ganta wonders the same thing about the drugs apparent positive effects on several conditions, from dementia to sleep apnea: Is it that obesity is causing or contributing to the problem [and that weight loss is causing the improvement], or is the medication directly having an impact through a different mechanism? She hopes there will be more research to parse this out in the years to come
A microdosing tirzepatide chart can guide this more gradual introduction
Tirzepatide is a strong fit for adults working toward meaningful weight loss who havent reached their goals with diet and exercise alone
The single-dose vials and single-dose pens including the cheaper vials many patients have been buying through LillyDirect are explicitly excluded
